What is Tango Therapeutics's stock issuance proceeds?

Tango Therapeutics (TNGX) reported stock issuance proceeds of $17.61M in Q1 2026.

How has Tango Therapeutics's stock issuance proceeds changed year-over-year?

Tango Therapeutics's stock issuance proceeds increased by 880150.0% year-over-year, from $2K to $17.61M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Tango Therapeutics TNGX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Gilead SciencesGILD

$166M-34.1%

ExelixisEXEL

$7.47M-35.7%

Cogent Biosciences, Inc.COGT

$5.76M+4,132%

CG OncologyCGON

$391.55M+57,312%

Lantheus HoldingsLNTH

$0-100%

ImmunityBio, Inc.IBRX

$971K+341%

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Enterprise value$4.43B+2,204%

P/S79.9×+74.4×

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's stock issuance proceeds?: Tango Therapeutics (TNGX) reported stock issuance proceeds of $17.61M in Q1 2026.
How has Tango Therapeutics's stock issuance proceeds changed year-over-year?: Tango Therapeutics's stock issuance proceeds increased by 880150.0% year-over-year, from $2K to $17.61M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.